AMY WEEKS: Open Payments
NPI 1225771595 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 38 payments from 21 companies in 2025. Trend: 2023 $13 · 2024 $742 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $119 |
| Ferring Pharmaceuticals Inc. | 5 | $100 |
| ABBVIE INC. | 4 | $97 |
| Astellas Pharma US Inc | 2 | $50 |
| ConvaTec Inc. | 1 | $43 |
| Boston Scientific Corporation | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Myriad Genetic Laboratories, Inc. | 2 | $42 |
| Dendreon Pharmaceuticals LLC | 2 | $40 |
| Procept Biorobotics Corporation | 1 | $38 |
Products named: ADSTILADRIN, BOTOX, ORGOVYX, GEMTESA, Xtandi, GENTLECATH GLIDE, Nubeqa, PROVENGE.
Industry payments across GA — which companies pay providers there.
